相关实验视频

Updated: Jan 10, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

在美国,复合性疹疫苗覆盖率的差异

David Singer¹, Nikita Stempniewicz¹, Lydia Lee¹

¹GSK, Philadelphia, Pennsylvania, USA.

Population health management

|November 28, 2025

概括

2020年,仅有14.1%的50岁及以上的美国成年人接受了复合性疹疫苗 (RZV). 在种族,种族和社会经济群体之间观察到RZV覆盖率的显著差异,表明需要更公平的疫苗接种策略.

科学领域:

公共卫生公共卫生
疫苗学疫苗学疫苗学
流行病学流行病学

背景情况:

2020年,在美国,对50岁及以上的成年人推使用复合性疹疫苗 (RZV).
疹是严重的公共卫生问题,特别是在老年人中.

研究的目的:

评估2020年在50岁及以上的非医疗机构住院的美国成年人中,复合性疹疫苗 (RZV) 的覆盖率.
确定与RZV吸收相关的人口和社会经济因素,并探索覆盖范围的差异.

主要方法:

来自2020年国家健康访谈调查的横截面数据的回顾性分析.
使用后勤回归来检查受访者特征与RZV覆盖范围之间的关联.
样本权重被应用以确保美国人口的代表性.

主要成果:

据估计,到2020年,在50岁以上的美国成年人中,有14.1%的人至少接受了一剂RZV.
覆盖范围因种族/族裔,教育程度,收入,年龄,医疗保险状况,最近一次医疗检查以及流感疫苗接种状况而有很大差异.
多变量分析确定了黑人/非洲裔美国人种族,西班牙裔种族,年龄较小 (50-59岁),收入较低,医疗访问不频繁,以及缺乏流感疫苗接种,这些因素与较低的RZV覆盖率有关.

结论:

在美国老年人中,RZV覆盖率仍然很低,在各个子组中观察到很大的差异.
这些发现突出了通过有针对性和公平的疫苗接种计划来加强疹预防的关键机会.
解决社会经济和种族/民族差异对于改善整体的RZV吸收和对带状疹的保护至关重要.

关键词:

不同的差异,不平等的差异.民族身份民族身份疹子疹子疹子竞争竞争竞争竞争复合性疹疫苗复合性疹疫苗在社会经济方面.

更多相关视频

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

相关概念视频

Vaccinations

Vaccinations

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

Cross-reactivity

Cross-reactivity

Diversity of Antigen Receptors

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...

Bias in Epidemiological Studies

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:

Relative Risk

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...